I am sure your have heard of famous Hollywood actor Michael J. Fox and his struggle with Parkinson’s diseases. Parkinson’s disease is one of the motor system disorders, which are the result of the loss of dopamine-producing brain cells. Pharmaceutical, Medical device companies and researchers around the world are trying to pin down the causes for Parkinson’s disease to come up with better and better treatments as current treatment options are limited. A collaborative research between the U.S., U.K., Germany, France, the Netherlands, and Iceland lead to discovery of a new set of genetic variants that could lead to the development of Parkinson’s disease.
What are symptoms of Parkinson’s disease?
The four primary symptoms of Parkinson’s disease re tremor, or trembling in hands, arms, legs, jaw, and face; rigidity, or stiffness of the limbs and trunk; bradykinesia, or slowness of movement; and postural instability, or impaired balance and coordination.
What does latest gene researcher on Parkinson’s disease reveal?
Researchers found five variants of genes that affect Parkinson’s disease. Researchers acknowledged that it is not the first time the genes have been discovered, but it adds to pool of six genetic factors that were discovered previously. The amazing part of...
this research is that first time researchers browsed through about 7.7 million possible gene variants for Parkinson’s disease.
Having more gene variant mean more changes for Parkinson’s disease?
The findings regarding gene variants are still new and researchers have limited knowledge. Although the finding is not clinically validated, but still, researchers reveal that 20% of patients with the highest number of risk variants were 2.5 times more likely to develop Parkinson’s disease.
There is focus on Parkinson’s disease and medical device industry is working on developing minimally invasive devices based on neuro-stimulation. I hope that the clinical studies are able to validate new findings and more treatment options can be developed for people suffering for Parkinson’s disease.